FUTIBATINIB

222 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking FUTIBATINIB:

# Side effect Count
0 DIARRHOEA 39
1 HYPERPHOSPHATAEMIA 36
2 DEATH 32
3 DISEASE PROGRESSION 31
4 FATIGUE 28
5 NAUSEA 26
6 DRY MOUTH 24
7 OFF LABEL USE 20
8 VOMITING 18
9 ONYCHOMADESIS 17
See all common reactions for FUTIBATINIB

FUTIBATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ORAL HERPES ZOSTER 1 0.0455
1 HER2 POSITIVE GASTRIC CANCER 1 0.0312
2 RETROPERITONEAL NEOPLASM METASTATIC 1 0.0303
3 ORAL HYPERAESTHESIA 1 0.0222
4 HYPERPHOSPHATAEMIA 36 0.0167
5 PUNCTURE SITE INFECTION 1 0.0161
6 NAIL DEFORMATION 1 0.0149
7 NAIL TOXICITY 4 0.0133
8 LIVER ABLATION 1 0.0132
9 TRICHOMEGALY 1 0.0109
See all enriched reactions for FUTIBATINIB